Literature DB >> 17632080

TFDP3 inhibits E2F1-induced, p53-mediated apoptosis.

Chan Tian1, Dan Lv, Huan Qiao, Jun Zhang, Yan-hui Yin, Xiao-ping Qian, Yu-ping Wang, Yu Zhang, Wei-feng Chen.   

Abstract

By dimerizing with E2F proteins, TFDP has profound influence on cellular E2F activities. While TFDP1 and 2 enhance the DNA binding and the transcriptional activity of E2F, the newly identified member of the DP family, TFDP3 primarily functions as a negative regulator. To further characterize the inhibitory property of TFDP3, the present study specifically examined the modulatory role of TFDP3 on E2F1-induced cell death. HEK-293 cells underwent apoptosis following ectopic expression of E2F1. This effect was virtually abolished by co-transfection with TFDP3. In the meantime, the accumulation of p53 proteins and the increased expression of the pro-apoptotic molecules, including Bax, Puma, Noxa, and Bid were found to be suppressed. These data suggest a new mechanism for the regulation of E2F1-induced apoptosis and provide further evidence for the general involvement of TFDP3 in the regulation of E2F functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632080     DOI: 10.1016/j.bbrc.2007.06.128

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  E2F-1 regulation by an unusual DNA damage-responsive DP partner subunit.

Authors:  L Ingram; S Munro; A S Coutts; N B La Thangue
Journal:  Cell Death Differ       Date:  2010-06-18       Impact factor: 15.828

Review 2.  Small molecule regulators of Rb-E2F pathway as modulators of transcription.

Authors:  Sandeep Singh; Jackie Johnson; Srikumar Chellappan
Journal:  Biochim Biophys Acta       Date:  2010-07-15

3.  Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.

Authors:  Hai-Xiang Sun; Yang Xu; Xin-Rong Yang; Wei-Min Wang; Haibo Bai; Ruo-Yu Shi; Suresh K Nayar; Ranjan P Devbhandari; Yi-zhou He; Qin-Feng Zhu; Yun-Fan Sun; Bo Hu; Mehtab Khan; Robert A Anders; Jia Fan
Journal:  Hepatology       Date:  2013-02-07       Impact factor: 17.425

4.  Intestine-specific homeobox (ISX) upregulates E2F1 expression and related oncogenic activities in HCC.

Authors:  Shen-Nien Wang; Li-Ting Wang; Ding-Ping Sun; Chee-Yin Chai; Edward Hsi; Hsing-Tao Kuo; Kazunari K Yokoyama; Shih-Hsien Hsu
Journal:  Oncotarget       Date:  2016-06-14

5.  Effects of cancer-testis antigen, TFDP3, on cell cycle regulation and its mechanism in L-02 and HepG2 cell lines in vitro.

Authors:  Yunshen Jiao; Lingyu Ding; Ming Chu; Tieshan Wang; Jiarui Kang; Xiaofan Zhao; Huanhuan Li; Xi Chen; Zirui Gao; Likai Gao; Yuedan Wang
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

6.  TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia.

Authors:  Ming Chu; Kailin Yin; Yujun Dong; Pingzhang Wang; Yun Xue; Peng Zhou; Yuqi Wang; Yuedan Wang
Journal:  Oncotarget       Date:  2017-01-03

7.  TFDP3 Regulates Epithelial-Mesenchymal Transition in Breast Cancer.

Authors:  Kailin Yin; Yanchen Liu; Ming Chu; Yuedan Wang
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

8.  TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231.

Authors:  Ling-Yu Ding; Ming Chu; Yun-Shen Jiao; Qi Hao; Peng Xiao; Huan-Huan Li; Qi Guo; Yue-Dan Wang
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

9.  Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients.

Authors:  Deyu Zhang; Siran Zhou; Bingrong Liu
Journal:  Biomed Res Int       Date:  2020-03-20       Impact factor: 3.411

10.  Identification of candidate genes for human pituitary development by EST analysis.

Authors:  Yueyun Ma; Xiaofei Qi; Jianjun Du; Shaojun Song; Dongyun Feng; Jia Qi; Zhidong Zhu; Xin Zhang; Huasheng Xiao; Zeguang Han; Xiaoke Hao
Journal:  BMC Genomics       Date:  2009-03-15       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.